Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000733851 | SCV000617818 | uncertain significance | not provided | 2022-11-29 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV000550343 | SCV000640840 | likely benign | Nemaline myopathy 2 | 2024-12-04 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000733851 | SCV000861952 | uncertain significance | not provided | 2018-06-13 | criteria provided, single submitter | clinical testing | |
Hudson |
RCV000550343 | SCV000993627 | uncertain significance | Nemaline myopathy 2 | 2019-03-15 | criteria provided, single submitter | research | |
Revvity Omics, |
RCV000733851 | SCV003814120 | uncertain significance | not provided | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000550343 | SCV001458316 | uncertain significance | Nemaline myopathy 2 | 2020-01-17 | no assertion criteria provided | clinical testing |